Mark Levis (Hematologic Malignancies/Oncology, Johns Hopkins University, United States of America)
Session information
Symposium
Symposium 8 Novel therapeutic strategy for AML
Sat. Oct 13, 2018 2:50 PM - 5:00 PM No.10 (Osaka International Convention Center, 10F 1009)
Chairs: Hitoshi Kiyoi (Department of Hematology and Oncoloogy , Nagoya University Graduate School of Medicine, Japan), Takahiro Yamauchi (Department of Hematology and Oncoloogy , Universityl of Fukui, Japan)
【E】
Toshihiro Miyamoto (Medicine and Biosystemic Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan)
Yosuke Minami1, Nobuaki Fukushima2, Seiji Kakiuchi3, Hironobu Minami3, Hitoshi Kiyoi2, Tomoki Naoe4 (1.Department of Hematol., National Cancer Center Hos. East, Japan, 2.Department of Hematol. and Oncol., Nagoya University Graduate School of Med., Japan, 3.Department of Oncol. and Hematol., Kobe University Graduate School of Med., Japan, 4.National Hospital Organization Nagoya Medical Center, Japan)
Bruno C. Medeiros (Medicine/Hematology, Stanford University, United States of America)
Masashi Sanada (Clinical Research Center, Nagoya Medical Center, Nagoya, Japan)